Surgical Management of Gastric Carcinoma
For resectable gastric cancer, perform either distal or total gastrectomy with D2 lymphadenectomy as the standard curative approach, selecting the procedure based on tumor location and ensuring adequate resection margins. 1
Type of Gastrectomy Selection
Distal Gastrectomy
Indicated for distal gastric tumors when adequate proximal margins can be achieved:
- Requires 3 cm proximal margin for T2+ tumors with expansive growth (Types 1 and 2) 2, 1
- Requires 5 cm proximal margin for infiltrative growth patterns (Types 3 and 4) and diffuse Lauren histotype 3
- For T1 tumors, a 2 cm gross margin is sufficient 1
- When margins are uncertain, perform frozen section examination intraoperatively 2, 1
Total Gastrectomy
Mandatory in these specific situations:
- Proximal tumors where adequate distal stomach preservation is impossible 2, 1
- Pancreatic invasion requiring pancreatectomy, regardless of tumor location 1
- Tumors along the greater curvature of the corpus or fundus without adequate surgical margins 3
- Tumors with metastasis to station 4sb lymph nodes along the greater curvature, even if technically removable by distal gastrectomy 1
Function-Preserving Options (Early Cancer Only)
For cT1cN0 tumors, consider modified procedures:
- Pylorus-preserving gastrectomy: Middle stomach tumors with distal border ≥4 cm proximal to pylorus 2
- Proximal gastrectomy: Proximal tumors where >50% of distal stomach can be preserved 2
- These remain investigational for more advanced stages 1
Lymphadenectomy Extent
D2 Lymphadenectomy (Standard)
Indicated for all potentially curable T2-T4 tumors and cT1N+ tumors 2, 1:
For Distal Gastrectomy D2:
- Stations 1,3, 4sb, 4d, 5,6,7, 8a, 9, 11p, 12a 2
For Total Gastrectomy D2:
- Stations 1-7, 8a, 9,10, 11p, 11d, 12a 2
D1+ Lymphadenectomy
Indicated for cT1N0 tumors (except very early cancers):
- D1 nodes plus stations 8a and 9 2
D1 Lymphadenectomy
Only for T1a tumors not meeting endoscopic resection criteria, or cT1bN0 differentiated tumors ≤1.5 cm 2, 1
Critical Anatomical Considerations
Splenectomy Decision
Spleen preservation is now standard based on JCOG0110 trial demonstrating noninferiority 3:
- Perform splenectomy only when:
- Routine prophylactic splenectomy increases complications without survival benefit 3
Pancreas Preservation
Distal pancreas should NOT be routinely removed 4:
- Remove only with direct tumor invasion in proximal gastric cancers 4
- Pancreaticosplenectomy for distal two-thirds tumors shows no benefit 4
Omentectomy
Greater omentum removal is standard for T3+ tumors 3:
- For T1/T2 tumors, preserve omentum >3 cm from gastroepiploic arcade 3
- Bursectomy may benefit T3+ tumors with posterior wall involvement but avoid in T1/T2 to prevent pancreatic injury 3
Reconstruction Techniques
After Distal Gastrectomy
Roux-en-Y reconstruction is preferred over Billroth I/II for superior functional outcomes and reduced bile reflux 3:
- Billroth II acceptable for tumors invading pylorus/duodenum (allows re-operation if recurrence) 5
- Pouch reconstruction may improve quality of life but requires technical expertise 6
After Total Gastrectomy
Roux-en-Y esophagojejunostomy is standard 3:
- Simplest technique with satisfactory functional results 3
- Jejunal pouch construction may improve nutritional outcomes 6
After Proximal Gastrectomy
Modified tubular gastroesophageal anastomosis or jejunal interposition reduces severe reflux compared to simple esophagogastrostomy 5
Minimally Invasive Approaches
Laparoscopic Surgery
Established as equivalent to open surgery for:
- cT1N0 and cT1N1 distal gastrectomy with D2 lymphadenectomy 5, 7
- Provides faster recovery with equivalent oncological outcomes 5, 8
For advanced gastric cancer:
- Perform only in high-volume experienced centers 5
- Long-term survival data from ongoing trials pending 5
Robotic Surgery
Emerging technique showing promise for enhanced lymphadenectomy precision 6, 8:
- Preliminary data suggest potential advantages in early postoperative recovery 6
- Requires further validation studies 6
Extended Resections
Combined Organ Resection
Perform en bloc resection of directly invaded adjacent organs when R0 resection achievable 1:
- Liver, colon, diaphragm as needed
- Avoid non-curative extended resections 1
Para-aortic Lymphadenectomy
Not routinely recommended - JCOG9501 trial showed no survival benefit 1:
- Consider only in clinical trials for selected patients 5
Station 14v Dissection
Consider for clinically stage III middle/lower third tumors with extensive nodal disease, particularly infrapyloric metastases 5:
- Not part of routine D2 dissection 5
Common Pitfalls to Avoid
Inadequate margins: Always verify with frozen section if macroscopic margins questionable - positive margins dramatically worsen prognosis 1
Incomplete D2 lymphadenectomy: Minimum 15 lymph nodes required for accurate staging; incomplete dissection causes stage migration 4
Routine splenectomy: Outdated practice that increases morbidity without benefit 3
Inadequate preoperative marking: Use endoscopic clips for unclear tumor borders, especially in infiltrative types 1
Inappropriate function-preserving surgery: Reserve for confirmed early cancer only; understaging leads to inadequate treatment 1
Special Populations
Esophagogastric Junction Tumors
For adenocarcinoma proximal to EGJ: Consider esophagectomy with proximal gastrectomy and gastric tube reconstruction, similar to esophageal cancer approach 2, 1
Hereditary Gastric Cancer (CDH1 mutations)
Prophylactic total gastrectomy is recommended for pathogenic CDH1 mutation carriers 8
Oligometastatic Disease
Reduction surgery (gastrectomy for metastatic disease) is NOT recommended - REGATTA trial (JCOG0705) showed no survival benefit 1:
- Surgery only for palliation of bleeding/obstruction 1